Latest AI and machine learning research in leukemia for healthcare professionals.
Chronic lymphocytic leukemia (CLL) is a malignancy caused by the overexpression of the anti-apoptoti...
Chronic kidney disease (CKD) significantly increases the risk of CVD diseases, particularly among el...
Artificially designed, functional nanostructured surfaces, called metasurfaces, are an emerging plat...
Early and highly accurate detection of rapidly damaging deadly disease like Acute Lymphoblastic Leuk...
Chronic heart failure (CHF) poses a significant threat to human health. The stress hyperglycemia rat...
Hepatoid adenocarcinoma of the stomach (HAS) is a rare subtype of gastric cancer characterized by hi...
OBJECTIVE: This study aims to evaluate the association between the white blood cell-to-platelet rati...
OBJECTIVE: This study aims to evaluate key factors influencing the short-term and long-term prognosi...
This study aims to construct and validate noninvasive diagnosis models for evaluating significant li...
Deep learning-based image segmentation has allowed for the fully automated, accurate, and rapid anal...
A symbiotic relationship exists between narrative imaginaries of and real-life advancements in techn...
INTRODUCTION: Obesity, defined as a body mass index ≥30 kg/m, is a major public health concern in th...
Donor-derived cell-free DNA (dd-cfDNA) in the peripheral blood of allograft recipients has shown to...
A 78-year-old female patient was initially treated with laparoscopic radical cholecystectomy for gal...
In recent years, immune checkpoint inhibitors (ICIs) has emerged as a fundamental component of the s...
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) has become standar...
BACKGROUND: Elevated vitamin B12 (B12) levels are linked to an increased risk of cancers, including ...
Deep-tissue solid cancer treatment has a poor prognosis, resulting in a very low 5-year patient surv...
Tumor cell nuclear size (NS) indicates malignant potential in breast cancer; however, its clinical s...
PURPOSE: Ovarian cancer patients with a Homologous Recombination Deficiency (HRD) often benefit from...
We employed a mechanistic learning approach, integrating on-treatment tumor kinetics (TK) modeling w...